Northrop Grumman (NOC) Reports Q3 Earnings: What Key Metrics Have to Say

21.10.25 15:30 Uhr

Werte in diesem Artikel
Aktien

512,60 EUR -2,80 EUR -0,54%

Indizes

6.875,2 PKT 83,5 PKT 1,23%

Northrop Grumman (NOC) reported $10.42 billion in revenue for the quarter ended September 2025, representing a year-over-year increase of 4.3%. EPS of $7.67 for the same period compares to $7.00 a year ago.The reported revenue represents a surprise of -2.78% over the Zacks Consensus Estimate of $10.72 billion. With the consensus EPS estimate being $6.49, the EPS surprise was +18.18%.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.Here is how Northrop Grumman performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:Sales- Intersegment eliminations: $-569 million versus the four-analyst average estimate of $-501.43 million. The reported number represents a year-over-year change of -13.7%.Sales- Mission Systems: $3.09 billion versus $3 billion estimated by four analysts on average. Compared to the year-ago quarter, this number represents a +9.6% change.Sales- Space Systems: $2.7 billion versus $2.51 billion estimated by four analysts on average. Compared to the year-ago quarter, this number represents a -6% change.Sales- Defense Systems: $2.06 billion versus the four-analyst average estimate of $2.5 billion. The reported number represents a year-over-year change of -1.2%.Sales- Aeronautics Systems: $3.14 billion compared to the $3.21 billion average estimate based on four analysts. The reported number represents a change of +9.2% year over year.Operating income (loss)- Intersegment eliminations: $-75 million compared to the $-71.19 million average estimate based on four analysts.Operating income (loss)- Defense Systems: $234 million compared to the $236.83 million average estimate based on four analysts.Operating income (loss)- Mission Systems: $515 million versus the four-analyst average estimate of $458.41 million.Operating income (loss)- Space Systems: $298 million versus the four-analyst average estimate of $306.1 million.Operating income (loss)- Aeronautics Systems: $305 million versus the four-analyst average estimate of $310.97 million.Segment operating income adjustment- Unallocated corporate expenses: $-102 million versus $-99.96 million estimated by three analysts on average.Segment operating income adjustment- FAS/CAS operating adjustment: $67 million versus $63.92 million estimated by three analysts on average.View all Key Company Metrics for Northrop Grumman here>>>Shares of Northrop Grumman have returned +4.5% over the past month versus the Zacks S&P 500 composite's +1.2% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.5 Stocks Set to DoubleEach was handpicked by a Zacks expert as the favorite stock to gain +100% or more in the months ahead. They includeStock #1: A Disruptive Force with Notable Growth and ResilienceStock #2: Bullish Signs Signaling to Buy the DipStock #3: One of the Most Compelling Investments in the MarketStock #4: Leader In a Red-Hot Industry Poised for GrowthStock #5: Modern Omni-Channel Platform Coiled to SpringMost of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor. While not all picks can be winners, previous recommendations have soared +171%, +209% and +232%.Download Atomic Opportunity: Nuclear Energy's Comeback free today.Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Northrop Grumman Corporation (NOC): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

In eigener Sache

Übrigens: Northrop Grumman und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und Neukunden-Bonus sichern!

Ausgewählte Hebelprodukte auf Northrop Grumman

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Northrop Grumman

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu Northrop Grumman Corp.

Wer­bung

Analysen zu Northrop Grumman Corp.

DatumRatingAnalyst
29.03.2018Northrop Grumman OverweightBarclays Capital
26.10.2017Northrop Grumman OutperformRBC Capital Markets
12.01.2017Northrop Grumman OutperformRBC Capital Markets
10.11.2016Northrop Grumman OverweightBarclays Capital
06.10.2016Northrop Grumman OutperformRobert W. Baird & Co. Incorporated
DatumRatingAnalyst
29.03.2018Northrop Grumman OverweightBarclays Capital
26.10.2017Northrop Grumman OutperformRBC Capital Markets
12.01.2017Northrop Grumman OutperformRBC Capital Markets
10.11.2016Northrop Grumman OverweightBarclays Capital
06.10.2016Northrop Grumman OutperformRobert W. Baird & Co. Incorporated
DatumRatingAnalyst
19.05.2016Northrop Grumman Sector PerformRBC Capital Markets
02.05.2016Northrop Grumman Equal WeightBarclays Capital
30.04.2015Northrop Grumman NeutralUBS AG
12.02.2015Northrop Grumman Equal WeightBarclays Capital
19.10.2012Northrop Grumman performOppenheimer & Co. Inc.
DatumRatingAnalyst
13.09.2012Northrop Grumman sellUBS AG
14.06.2006Update Northrop Grumman Corp.: UnderperformGoldman Sachs

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Northrop Grumman Corp. nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen